Method of retarding and ameliorating central nervous system and eye damage
DC CAFC
First Claim
Patent Images
1. A method of treating an individual suffering from retinal damage or retinal disease, said method comprising administering a therapeutically effective amount of astaxanthin to the individual to improve the vision of the individual.
1 Assignment
Litigations
2 Petitions
Accused Products
Abstract
A method of retarding and ameliorating eye diseases and injuries is disclosed. The method comprises administering astaxanthin in a therapeutically-effective amount to prevent, retard or treat eye and central nervous system diseases or injuries, such as age-related macular degeneration and other central nervous system degenerative diseases, photic injury, ischemic diseases, and inflammatory diseases.
140 Citations
27 Claims
- 1. A method of treating an individual suffering from retinal damage or retinal disease, said method comprising administering a therapeutically effective amount of astaxanthin to the individual to improve the vision of the individual.
-
13. A method of treating an individual comprising administering a therapeutically effective amount of astaxanthin to the individual to protect neurons in a retina of the individual from free-radical induced retinal injury.
- 14. A method of treating an individual suffering from neuronal damage to a retina comprising administering a therapeutically-effective amount of astaxanthin to the individual to improve the condition of the retina.
-
16. A method of treating an individual suffering from age-related macular degeneration comprising administering a therapeutically-effective amount of astaxanthin to the individual to retard the progress of age-related macular degeneration.
- 17. A method of treating an individual suffering from an ischemic or intraocular pressure-related disease of a retina comprising administering a therapeutically-effective amount of astaxanthin to the individual to improve the condition of the retina and to prevent further damage to the retina.
- 19. A method of treating an individual suffering from an inflammatory disease of a retina comprising administering a therapeutically effective amount of astaxanthin to the individual to improve the condition of the retina and to prevent further damage to the retina.
- 21. A method of treating an individual suffering from a free radical-induced injury to a central nervous system, said method comprising administering a therapeutically-effective amount of astaxanthin to the individual to improve the condition of the central nervous system.
-
26. A method of treating an individual suffering from a degenerative retinal disease, said method comprising administering a therapeutically effective amount of astaxanthin to the individual to retard the progress of the disease.
-
27. A method of treating an individual suffering from a degenerative central nervous system disease of a brain or spinal cord, said method comprising administering a therapeutically effective amount of astaxanthin to the individual to retard the progress of the disease.
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
Litigation Data
-
Current AssigneeBoard of Trustees of The University of Illinois
-
Original AssigneeBoard of Trustees of The University of Illinois
-
InventorsTso, Mark O. M., Lam, Tim-Tak
-
Primary Examiner(s)Page, Thurman K.
-
Assistant Examiner(s)Webber, Pamela S.
-
Application NumberUS08/330,194Time in Patent Office600 DaysField of Search424/59, 424/60, 424/78.04, 424/427, 128/645, 514/912, 514/913, 514/914, 514/915, 514/929, 568/378US Class Current424/422CPC Class CodesA61K 31/12 KetonesA61P 27/00 Drugs for disorders of the ...A61P 27/06 Antiglaucoma agents or miotics
